Dexamethasone reduced mortality among patients hospitalized with COVID-19, especially those who were also receiving respiratory support.

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

The second possibility is that Covid has now settled into a rut, which will see it become progressively milder until it ...

Dexamethasone: The Game-Changer The first true success of drug repurposing in treating COVID-19 came with the discovery that ...

Currently, the drug dexamethasone is still the only therapeutic shown to be effective against the novel coronavirus for severe patients, the chief of the World Health Organization said Friday.

While dexamethasone, a commonly used corticosteroid, is a standard treatment for severe COVID-19, the study found that it modestly inhibited the release of arginase-1 from neutrophils. This was ...